-
Je něco špatně v tomto záznamu ?
Insights on Multiple Myeloma Treatment Strategies
MV. Mateos, H. Ludwig, A. Bazarbachi, M. Beksac, J. Bladé, M. Boccadoro, M. Cavo, M. Delforge, MA. Dimopoulos, T. Facon, C. Geraldes, H. Goldschmidt, R. Hájek, M. Hansson, K. Jamroziak, M. Leiba, T. Masszi, L. Mendeleeva, M. O'Dwyer, T. Plesner,...
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, přehledy
NLK
Directory of Open Access Journals
od 2017
PubMed Central
od 2017
Europe PubMed Central
od 2017
Wiley Free Content
od 2017
Wiley-Blackwell Open Access Titles
od 1997
ROAD: Directory of Open Access Scholarly Resources
od 2017
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
The introduction of new agents and management strategies over the past decade has resulted in a major step change in treatment outcomes with deepening responses and increased survival for patients with multiple myeloma. In daily clinical practice, healthcare professionals are now faced with challenges including, optimal treatment sequencing and changing treatment goals. In light of this, a group of experts met to discuss diagnostic and treatment guidelines, examine current clinical practice, and consider how new clinical trial data may be integrated into the management of multiple myeloma in the future.
3rd Department of Internal Medicine Semmelweis University Budapest Hungary
Ankara University School of Medicine Ankara Turkey
Cancer Institute University College London London United Kingdom
Clínica Universidad de Navarra CIMA CIBERONC IDISNA Pamplona Spain
Department of Hematology Erasmus MC Cancer Institute Rotterdam The Netherlands
Department of Hematology Skåne University Hospital und Lund University Lund Sweden
Department of Hematology VU University Medical Center Amsterdam The Netherlands
Department of Internal Medicine American University of Beirut Beirut Lebanon
Galway University Hospital Galway Ireland
Hospital and University Centre of Coimbra Coimbra Portugal
Institut d'Investigac'ons Biomedques August Pi Sunyer Barcelona Spain
Institute of Hematology and Transfusion Medicine Warsaw Poland
Klinikum Schwabing München Germany
School of Medicine National and Kapodistrian University of Athens Athens Greece
Seràgnoli Institute of Hematology Bologna University School of Medicine Bologna Italy
Service des Maladies du Sang Hôpital Claude Huriez Lille France
University Clinical Center Ljubljana and Medical Faculty Ljubljana Slovenia
University Hospital Leuven Leuven Belgium
University of Nantes Nantes France
Vejle Hospital and University of Southern Denmark Vejle Denmark
Wilhelminen Cancer Research Institute Wilhelminenspital Vienna Austria
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19044046
- 003
- CZ-PrNML
- 005
- 20200115134443.0
- 007
- ta
- 008
- 200107s2019 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/HS9.0000000000000163 $2 doi
- 035 __
- $a (PubMed)31723802
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Mateos, María-Victoria $u Complejo Asistencial Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (CAUSA/IBSAL), Salamanca, Spain.
- 245 10
- $a Insights on Multiple Myeloma Treatment Strategies / $c MV. Mateos, H. Ludwig, A. Bazarbachi, M. Beksac, J. Bladé, M. Boccadoro, M. Cavo, M. Delforge, MA. Dimopoulos, T. Facon, C. Geraldes, H. Goldschmidt, R. Hájek, M. Hansson, K. Jamroziak, M. Leiba, T. Masszi, L. Mendeleeva, M. O'Dwyer, T. Plesner, JF. San-Miguel, C. Straka, NWCJ. van de Donk, K. Yong, S. Zver, P. Moreau, P. Sonneveld,
- 520 9_
- $a The introduction of new agents and management strategies over the past decade has resulted in a major step change in treatment outcomes with deepening responses and increased survival for patients with multiple myeloma. In daily clinical practice, healthcare professionals are now faced with challenges including, optimal treatment sequencing and changing treatment goals. In light of this, a group of experts met to discuss diagnostic and treatment guidelines, examine current clinical practice, and consider how new clinical trial data may be integrated into the management of multiple myeloma in the future.
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Ludwig, Heinz $u Wilhelminen Cancer Research Institute, Wilhelminenspital, Vienna, Austria.
- 700 1_
- $a Bazarbachi, Ali $u Department of Internal Medicine, American University of Beirut, Beirut, Lebanon.
- 700 1_
- $a Beksac, Meral $u Ankara University School of Medicine, Ankara, Turkey.
- 700 1_
- $a Bladé, Joan $u Institut d'Investigac'ons Biomedques August Pi Sunyer (IDiBAPS), Barcelona, Spain.
- 700 1_
- $a Boccadoro, Mario $u University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Turin, Italy.
- 700 1_
- $a Cavo, Michele $u Seràgnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy.
- 700 1_
- $a Delforge, Michel $u University Hospital Leuven, Leuven, Belgium.
- 700 1_
- $a Dimopoulos, Meletios A $u School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
- 700 1_
- $a Facon, Thierry $u Service des Maladies du Sang, Hôpital Claude Huriez, Lille, France.
- 700 1_
- $a Geraldes, Catarina $u Hospital and University Centre of Coimbra, Coimbra, Portugal.
- 700 1_
- $a Goldschmidt, Hartmut $u Department of Internal Medicine V, University Clinic Heidelberg and National Center of Tumor Diseases, Heidelberg, Germany.
- 700 1_
- $a Hájek, Roman $u Department of Hematooncology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
- 700 1_
- $a Hansson, Markus $u Department of Hematology, Skåne University Hospital und Lund University, Lund, Sweden.
- 700 1_
- $a Jamroziak, Krzysztof $u Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
- 700 1_
- $a Leiba, Merav $u Assuta Ashdod University Hospital, Faculty of Health Science, Ben-Gurion University of the Negev, Negev, Israel.
- 700 1_
- $a Masszi, Tamás $u 3rd Department of Internal Medicine, Semmelweis University, Budapest, Hungary.
- 700 1_
- $a Mendeleeva, Larisa $u National Research Center for Hematology of the Ministry of Healthcare of the Russian Federation, Moscow, Russia.
- 700 1_
- $a O'Dwyer, Michael $u Galway University Hospital, Galway, Ireland.
- 700 1_
- $a Plesner, Torben $u Vejle Hospital and University of Southern Denmark, Vejle, Denmark.
- 700 1_
- $a San-Miguel, Jesús F $u Clínica Universidad de Navarra, CIMA, CIBERONC, IDISNA, Pamplona, Spain.
- 700 1_
- $a Straka, Christian $u Klinikum Schwabing, München, Germany.
- 700 1_
- $a van de Donk, Niels W C J $u Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
- 700 1_
- $a Yong, Kwee $u Cancer Institute, University College London, London, United Kingdom.
- 700 1_
- $a Zver, Samo $u University Clinical Center Ljubljana and Medical Faculty, Ljubljana, Slovenia.
- 700 1_
- $a Moreau, Philippe $u University of Nantes, Nantes, France.
- 700 1_
- $a Sonneveld, Pieter $u Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
- 773 0_
- $w MED00201259 $t HemaSphere $x 2572-9241 $g Roč. 3, č. 1 (2019), s. e163
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31723802 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200107 $b ABA008
- 991 __
- $a 20200115134816 $b ABA008
- 999 __
- $a ind $b bmc $g 1480635 $s 1082716
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 3 $c 1 $d e163 $e 20181227 $i 2572-9241 $m HemaSphere $n Hemasphere $x MED00201259
- LZP __
- $a Pubmed-20200107
